This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Pardee, Timothy
| Item Type | Name |
|
Academic Article
|
Mouse models of human AML accurately predict chemotherapy response.
|
|
Academic Article
|
Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner.
|
|
Academic Article
|
The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia.
|
|
Academic Article
|
Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 and Bim induction.
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Academic Article
|
Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia.
|
|
Academic Article
|
Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML).
|
|
Academic Article
|
The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML).
|
|
Academic Article
|
High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly.
|
|
Academic Article
|
Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML).
|
|
Academic Article
|
A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.
|
|
Academic Article
|
Effect of Intensive Chemotherapy on Physical, Cognitive, and Emotional Health of Older Adults with Acute Myeloid Leukemia.
|
|
Grant
|
Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia
|
|
Academic Article
|
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.
|
|
Academic Article
|
The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia.
|
|
Academic Article
|
Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit.
|
|
Academic Article
|
A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia.
|